Home
Pipeline
- - - SPC-14
      Targeting Alzheimer’s
    - SPC-15
      Targeted prophylactic treatment—Stress-induced affective disorders
  - - SPU-16
      CNS Homing Peptide targeting Multiple Sclerosis
    - SP-26
      Fibromyalgia
  - - Drugs in the pipeline
      Pipeline Progress
      View our current pipeline
About Us
Investors
Contact Us

Select Page

Logo-13

May 27, 2022

Search for:

Silo Pharma

Silo Pharma Inc. is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including PTSD, stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. Silo focuses on developing novel therapies that are conventional drugs and psychedelic formulations.

Company

Home
Team
Advisory Board
Contact Us

Drug Pipeline

SPC-14
SPC-15
SP-26
SPU-16

Investors

Stock Information
SEC Filings
Board of Directors
Latest News
Email Alerts

Terms & Conditions Privacy Policy

Pipeline Progress

Logo-13